Finke Daniel, Hund Hauke, Frey Norbert, Luft Thomas, Lehmann Lorenz H
Department of Cardiology, Medizinische Klinik III, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
German Center for Cardiovascular Research (DZHK), Partnersite Heidelberg/Mannheim, Heidelberg, Germany.
Clin Res Cardiol. 2024 Sep 10. doi: 10.1007/s00392-024-02534-y.
Coronary interventions reduce morbidity and mortality in patients with acute coronary syndrome. However, the risk of mortality for patients with coronary artery disease (CAD) additionally depends on their systemic endothelial health status. The 'Endothelial Activation and Stress Index' (EASIX) predicts endothelial complications and survival in diverse clinical settings.
We hypothesized that EASIX may predict mortality in patients with CAD.
In 1283 patients undergoing coronary catheterization (CC) and having a diagnosis of CAD, EASIX was measured within 52 days (range - 1 year to - 14 days) before CC and correlated with overall survival. In an independent validation cohort of 1934 patients, EASIXval was measured within 174 days (+ 28 days to + 11 years) after CC.
EASIX predicted the risk of mortality after CC (per log2: hazard ratio (HR) 1.29, 95% confidence interval: [1.18-1.41], p < 0.001) in multivariable Cox regression analyses adjusting for age, sex, a high-grade coronary stenosis ≥ 90%, left ventricular ejection fraction, arterial hypertension and diabetes. In the independent cohort, EASIX correlated with EASIXval with rho = 0.7. The long-term predictive value of EASIXval was confirmed (per log2: HR 1.53, [1.42-1.64], p < 0.001) and could be validated by integrated Brier score and concordance index. Pre-established cut-offs (0.88-2.32) associated with increased mortality (cut-off 0.88: HR training: 1.63; HR validation: 1.67, p < 0.0001 and cut-off 2.32: HR training: 3.57; HR validation: 4.65, p < 0.0001).
We validated EASIX as a potential biomarker to predict death of CAD patients, irrespective of the timing either before or after catheterization.
冠状动脉介入治疗可降低急性冠状动脉综合征患者的发病率和死亡率。然而,冠状动脉疾病(CAD)患者的死亡风险还取决于其全身内皮健康状况。“内皮激活与应激指数”(EASIX)可预测不同临床环境下的内皮并发症和生存率。
我们假设EASIX可能预测CAD患者的死亡率。
在1283例接受冠状动脉造影(CC)且诊断为CAD的患者中,在CC前52天(范围为 - 1年至 - 14天)测量EASIX,并将其与总生存率相关联。在一个由1934例患者组成的独立验证队列中,在CC后174天(+ 28天至 + 11年)测量EASIXval。
在多变量Cox回归分析中,调整年龄、性别、≥90%的高度冠状动脉狭窄、左心室射血分数、动脉高血压和糖尿病后,EASIX可预测CC后的死亡风险(每log2:风险比(HR)1.29,95%置信区间:[1.18 - 1.41],p < 0.001)。在独立队列中,EASIX与EASIXval相关,rho = 0.7。EASIXval的长期预测价值得到证实(每log2:HR 1.53,[1.42 - 1.64],p < 0.001),并可通过综合Brier评分和一致性指数进行验证。预先设定的临界值(0.88 - 2.32)与死亡率增加相关(临界值0.88:HR训练组:1.63;HR验证组:1.67,p < 0.0001;临界值2.32:HR训练组:3.57;HR验证组:4.65,p < 0.0001)。
我们验证了EASIX作为预测CAD患者死亡的潜在生物标志物,无论其在导管插入术前还是术后。